Article

ISTA Pharmaceuticals begins Vitrase shipments

Irvine, CA—ISTA Pharmaceuticals has begun shipping units of pure ovine hyaluronidase for injection (Vitrase) in two sizes.

Irvine, CA-ISTA Pharmaceuticals has begun shipping units of pure ovine hyaluronidase for injection (Vitrase) in two sizes.

The product, which increases the absorption and dispersion of anesthetics and other injected drugs, is available in its ovine form in the single-use, 200 USP units/ml and the lyophilized, ovine version in multipurpose, 6,200 USP units.

The FDA approved the larger unit in May, and the smaller unit in December. The May approval ended the drug's tenure on the FDA's drug shortage list, where it had been since the previous manufacturer withdrew it from the market in 2001.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Deb Ristvedt, DO, on medications, lasers, and lifestyle in glaucoma management
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
© 2025 MJH Life Sciences

All rights reserved.